Changeflow GovPing Healthcare & Life Sciences FDA CDRH Variance Approval Letter for Photon GFX
Routine Notice Added Final

FDA CDRH Variance Approval Letter for Photon GFX

Email

Summary

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Photon GFX. This notice indicates a specific approval for a medical device variance, though no further details or documents are available for review.

Published by FDA on regulations.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The FDA's Center for Devices and Radiological Health (CDRH) has issued a variance approval letter to Photon GFX. This document, identified by FDA-2026-V-1684-0003, signifies a specific regulatory approval for a device variance. However, the content of the approval letter and any associated documents are not available for public viewing or download through the provided link.

Given the limited information, it is unclear what specific actions, if any, are required by other medical device manufacturers. Compliance officers should note this as an informational item regarding FDA's regulatory actions for specific device variances. No immediate compliance actions or deadlines are apparent from this notice.

Archived snapshot

Mar 18, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 1

Variance Approval Letter from FDA CDRH to Photon GFX

More Information
- Author(s) CDRH
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Medical device makers
Geographic scope
National (US) National (US)

Taxonomy

Primary area
Healthcare
Operational domain
Compliance
Topics
Medical Devices

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!